NIH Campus, Bethesda, MD
Description
Heart and Soul, Brain Behavior and Cardiovascular Gene Dosage Effects in 7q11.23 and 22q11.2 CNVs:
Williams-Beuren and 22q11.2 deletion/duplication syndromes in focus
Online registration will be open until 11:59 PM (EST) on Tuesday, 3/26/19. Onsite registration will be available throughout the event.
Abstract submission portal is now closed.The Heart and Soul workshop will bring together world experts on gene dosage effects in brain and cardiac development. Copy number variations in 7q11.23 (Williams Syndrome and the Duplication 7 syndrome) as well as in 22q11.2 (deletion and duplication syndromes) will serve as model conditions for this discussion. Speakers and participants will describe genotype-phenotype links, the molecular mechanisms by which gene dosage results in the syndrome phenotypes, and potential for therapeutic intervention, thus providing a rich and unique learning environment.
Trainees are welcome to attend and are encouraged to present. Short presentations will be selected from abstracts and a poster session is planned. Abstract awards will also be given.
Organizers
- Dr. Beth Kozel, Investigator and Lasker Clinical Research Scholar, Chief, Laboratory of Vascular and Matrix Genetics, NHLBI, Intramural Research Program
- Dr. Karen Berman, Senior Investigator & Chief, Clinical and Translational Neuroscience Branch, NIMH, Intramural Research Program
Speakers and Session Chairs:
- Dr. Christopher Austin, National Center for Advancing Translational Sciences, NIH
- Dr. Antonio Baldini, Consiglio Nationale delle Ricerche
- Dr. Anne Bassett, , University of Toronto
- Dr. Carrie Bearden, University of California, Los Angeles
- Dr. Karen Berman, National Institute of Mental Health, NIH
- Dr. Jennifer Blackford, Vanderbilt University
- Dr. Manfred Boehm, National Heart, Lung, and Blood Institute, NIH
- Dr. Caroline Burns, Harvard Medical School/Massachusetts General Hospital
- Dr. R. Thomas Collins, Stanford University
- Dr. William Gahl, National Human Genome Research Institute, NIH
- Dr. William Gaynor, Children's Hospital of Pennsylvania
- Dr. Elizabeth Goldmuntz, Children's Hospital of Pennsylvania
- Dr. Joshua Gordon, National Institute of Mental Health, NIH
- Dr. Eric Green, National Human Genome Research Institute, NIH
- Dr. Daniel Greif, Yale School of Medicine
- Dr. Raquel Gur, University of Pennsylvania
- Dr. Robert Hufnagel, National Eye Institute, NIH
- Dr. Beth Kozel, National Heart, Lung, and Blood Institute, NIH
- Dr. Anthony LaMantia, George Washington University
- Dr. Thomas Lehner, National Institute of Mental Health, NIH
- Dr. Bruno Marino, University of Rome
- Dr. Andrew Matisoff, Children's National Health Center
- Prof. Donna McDonald-McGinn, Children’s Hospital of Pennsylvania
- Dr. Robert Mecham, Washington University School of Medicine
- Dr. Carolyn Mervis, University of Louisville
- Dr. Bernice Morrow, Albert Einstein College of Medicine
- Dr. Lucy Osborne, University of Toronto
- Dr. Elaine Ostrander, National Human Genome Research Institute, NIH
- Dr. Barbara Pober, Harvard Medical School/Massachusetts General Hospital
- Dr. Silvia Racedo, Albert Einstein College of Medicine
- Dr. Armin Raznahan, National Institute of Mental Health, NIH
- Dr. Michael Shoykhet, Children’s National Medical Center
- Dr. Helen Tager-Flusberg, Boston University
- Dr. Audrey Thurm, National Institute of Mental Health, NIH
- Dr. Zsolt Urban, University of Pittsburgh
- Dr. Jacob Vorstman, Hospital for Sick Children
- Dr. Stephanie Ware, Indiana University School of Medicine
Contact
For questions related to the meeting, please contact:
- Phone: 301-594-3384
- Email: laurie.steiger@nih.gov
- Funding provided by National Heart, Lung, and Blood Institute (NHLBI)
- Funding provided by National Institute of Mental Health (NIMH)
- Concessions supported by the Williams Syndrome Association (WSA)
- Concessions supported by The International 22q11.2 Foundation Inc.